Post-IPO Equity - Diamyd Medical
Investment Firm
Overview
Diamyd Medical is a Swedish diabetes company active in the field of pharmaceutical development.
Announced Date
Apr 16, 2024
Closed on Date
Apr 18, 2024
Funding Type
Post Ipo Equity
Highlights
Location
Europe
Social
Investor Lead
N/A
Participant Investors
2
| Investor Name |
|---|
Round Details and Background
Diamyd Medical raised $5207282 on 2024-04-16 in Post-IPO Equity
Diamyd Medical is a Swedish diabetes company active in the field of pharmaceutical development.
Company Funding History
4
| Announcment Date | Transaction Name | Number Of Investors | Lead Investor | Money Raised |
|---|---|---|---|---|
| Mar 21, 2006 |  Pre Seed Round - Diamyd Medical | 1 | - | 100.0K |
| Apr 04, 2023 | Grant - Diamyd Medical | 1 | - | 5.0M |
| Apr 16, 2024 | Post-IPO Equity - Diamyd Medical | 2 | - | 5.2M |
| Apr 18, 2024 | Post-IPO Equity - Diamyd Medical | 2 | - | 5.2M |
Recent Activity
News
Apr 18, 2024
diamyd.com - Diamyd Medical announces final outcome in the company’s rights issue
News
Apr 18, 2024
News Powered by Cision - Diamyd Medical announces final outcome in the company’s rights issue
News
Apr 16, 2024
Diamyd Medical announces preliminary outcome in the company’s rights issue